Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Research

| More

Colgate Palmolive (India) - 1QFY17 Result Update - Volumes Recover but at a Cost - Reliance Securities

Posted On: 2016-08-15 20:08:53

Net sales of Colgate Palmolive (India) grew 8.9% yoy to Rs10.1bn, while EBITDA growth was recorded at 3.6% and PBT (before exceptional items) increased by just 1.7% to Rs1.9bn in the quarter ended June 30, 2016. It reported overall volume growth of 6% with domestic volume growing by 5%. While gross sales growth was higher at 12.5%, net sales grew just 8.9% on account of sharp 49% jump in tax outgo resulting from phasing out of Excise Duties benefits.

Going forward, we estimate the volume growth to pick up pace, especially with the launch of Cibaca Vedshakti in the naturals space at an attractive price point. However, this is likely to keep A&P spends at elevated levels, which would drag earnings growth, in our view. We expect the Company to report 12.7% and 10% CAGR in revenues and earnings through FY16-18E. We reiterate our HOLD recommendation on the stock with revised Target Price of Rs1,055.

Volumes Recovery in Process

Domestic business witnessed 5% volume growth during the quarter. Although, the Company has lost market share on yoy basis, it has recovered some share sequentially. Volume-wise, market share in toothpaste stood at 55.9% in June'16 vs. 55.3% in Mar'16 and 57.9% in 1HCY15. On the other hand, volume market share in Toothbrush was higher both on yoy as well as qoq basis. It stood at 46.8% in June'16 vs. 45.8% in Mar'16 and 42.7% in 1HCY15. The Company stated that new products such as Colgate Sensitive Clove & Colgate A1 Toothbrush led overall growth in the quarter.

Higher A&P Spend Drags EBITDA Margins

Weak demand environment and heightened competitive intensity resulted in 190bps rise in A&P spends to 15.5% of sales. With launch of Cibaca Vedshakti at 30% discount to effectively counter Patanjali Dant Kanti, we expect A&P spends to remain at elevated levels, going forward. Although gross margins were higher by 140bps, higher A&P and staff cost dragged EBITDA margins by 100bps to 20.3% during the quarter.

Outlook & Valuation

We expect Colgate to post revenues of Rs46.4bn & Rs52.4bn and net profit of Rs6.4bn & Rs7.3bn in FY17E & FY18E respectively. Based on expected EPS of Rs27, currently the stock trades at 37.7x FY18E earnings. While we expect volume growth and market shares to recover, higher A&P spends could cap earnings growth in coming quarters. We retain our HOLD rating on the stock with revised Target Price of Rs1,055, based on 38x June'16 earnings, which is a 10% discount to its average one-year forward multiple.

Shares of COLGATE-PALMOLIVE (INDIA) LTD. was last trading in BSE at Rs.956 as compared to the previous close of Rs. 960.95. The total number of shares traded during the day was 21150 in over 918 trades.

The stock hit an intraday high of Rs. 970.5 and intraday low of 951. The net turnover during the day was Rs. 20342655.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Company Visit Note: The Mandhana Retail Ventures Ltd - NOT RATED - Kotak
Banks : Offers protection in adverse conditions - A deeper study into Pradhan Mantri Fasal Bima Yojana - Agriculture Insurance scheme - Kotak
Energy - downstream PSUs: When the tide turns - Kotak
Company Update: Mahindra and Mahindra (M&M) - BUY - TP Rs.1565 - Kotak
Maharashtra government removes cap on taxi / auto licenses: Angel Broking
IPCA Labs - USFDA update: Angel Broking
Company Update: Gujarat State Petronet Ltd (GSPL) - ACCUMULATE - TP Rs.182 - Kotak
Management Meet Update - Zensar Technologies - CSEC Research
Company Update: VRL Logistics Ltd - BUY - TP Rs.375 - Kotak
Strategy: The impossible trinity of farm income - Kotak
Banks : Private banks accelerate gains on CASA : Deeper study into deposit profile of banks for FY2016 - Kotak
Company Update: Blue Star - ACCUMULATE - TP Rs.684 - Kotak
Banking : RBI gets into action - Kotak
Dr Reddy's - EIR for its Miryalaguda API plant: Angel Broking
Eris Lifesciences Limited - IPO Note - Angel Broking
Banks: Maharashtra announces farm loan waiver - Kotak
Company Update: Petronet LNG - ACCUMULATE - TP Rs.462 - Kotak
Company Update: Mirza International - REDUCE - TP Rs.161 - Kotak
Fiem Industries - BUY - TP Rs.1,254 - Kotak
Insurance: ICICI Prudential Life boosts industry growth - Kotak
Tejas Networks - A destination for high speed technology: Angel Broking
Hindalo Industries - Result Update - Strong show becoming a routine, maintain Buy - Centrum
Star Cement - Result Update - Profitability rebounds on better pricing, cost reduction - Centrum
FIEM Industries - Result Update - Negatives priced in, Well poised to gain in the long term - Centrum
Birla Corporation - Strong Q4 FY17; acquisition reporting strong numbers; Buy - Anand Rathi
Escorts Ltd - Ready for next leg - PhillipCapital
Earnings Update - Talwalkars Better Value Fitness (TBVF IN) - Results on expected line - CSEC Research
Result Update: Adani Port and Special Economic Zone (APZ) - BUY - TP Rs.425 - Kotak
Telecom: Two quarters of Jio - assessing the impact - Kotak
Earnings Update - Balkrishna Industries (BIL IN) - Strong volume growth continues - CSEC Research
Earnings Update - Kaveri Seeds Ltd(KSCL IN) - Muted performance - CSEC Research
Earnings Update - TTK Prestige (TTKPT IN) - Results in-line with expectation - CSEC Research
Earnings Update - Berger Paints (BRGR IN) - Results in-line with expectation - CSEC Research
Mayur Uniquoters - Footwear segment dragged performance; Maintain Hold - Awanish Chandra and Vikas Rajpal - Centrum
Ramco Cements - On solid footing; reiterate Buy - Rajesh Kumar Ravi and Vinay Menon - Centrum
Cadila gets US FDA approval for Mesalamine tablets: Angel Broking
Consumer Products: 4QFY17 review: better, but not quite there yet - Kotak
Earnings Update - MAHINDRA & MAHINDRA (MM IN) - Healthy performance led by FES - CSEC Research
Earnings Update -ITC (ITC IN) - Decent performance - CSEC Research
Earnings Update - Heidelberg Cements (HEIM IN) - Strong volumes; drive the earnings growth - CSEC Research
Cement: Cooling off - Kotak
Cadila Healthcare - 4QFY2017 Result Update - Angel Broking
Result Update: Moil - BUY - TP Rs.410 - Kotak
Result Update: Time Technoplast Ltd (TTL) - BUY - TP Rs.178 - Kotak
Earnings Update - Adani ports & SEZ (ADSEZ IN) - Healthy volume growth - CSEC Research
Pharma Update - Worst phase possibly behind us: Angel Broking
Result Update: Mold-Tek Packaging - ACCUMULATE - TP Rs.304 - Kotak
Result Update: IL&FS Transportation Networks Ltd - ACCUMULATE - TP Rs.112 - Kotak
Result Update: IRB INFRASTRUCTURE DEVELOPERS LTD - BUY - TP Rs.295 - Kotak
Mixed signals from May Auto sales volumes: Angel Broking


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017